Michael Meluzio

Executive Officer at Cue Biopharma.

Earliest Form D on file: Jul 2026

Filed Jul 22, 2026

Cue Biopharma

Biologics that modulate disease-specific T cells

Biotech, Boston MA

Named, Executive Officer.

$50M

sold of $50M offered

13 people

Sumita Ray, JD
Together on 1 filing
Executive Officer, signed as Chief Legal & Compliance Officer
Shao-Lee Lin
Together on 1 filing
Executive Officer, Director
Daniel Camardo
Together on 1 filing
Director
Dominic Borie
Together on 1 filing
Executive Officer
Pamela D. Garzone
Together on 1 filing
Director
Pasha Sarraf
Together on 1 filing
Director